PromoCell

PromoCell GmbH is a biotech company that helps scientists discover more every day. With 30 years of expertise, they are recognized globally for supplying scientists with the tools and training they need for groundbreaking research.

PromoCell offers more than 7,000 human cell culture and cell biology products, including human primary cells, stem cells, blood cells, media and optimized products for cancer and 3D cell culture. Their products are perfect for in-depth cell culture analysis, with kits and reagents for cell biology such as antibodies, ELISAs, cytokines, and growth factors.

All PromoCell products meet the highest ethical and legal standards. By complying with European biomedical conventions, they respect human rights and donor privacy. And they are committed to quality – in their products, training and customer services.

Each year 600 peer-reviewed publications feature PromoCell products. They operate in over 40 countries around the world, helping scientists with all of their research needs. And they offer over 100 ISO-certified training courses led by a team of in-house scientists at PromoCell Academy.

Bio-Connect is supplier of PromoCell products in the Benelux. You can find the products in our search engine. If you have any questions, please contact the helpdesk.



For more interesting cell culture video’s, visit the PromoCell YouTube channel.



Major product lines

  • Cells (primary, cancer, stem, blood)
  • Cell medium and culture
  • Cell analysis (PromoKine)

PromoCell news

Explainer video: HLA-Typed Primary Cells

The advantages of working with HLA in drug development research.



For more information, please visit: www.promocell.com




PromoCell is EXCiPACT™ GMP certified

The EXCiPACT™ GMP standard for pharmaceutical excipients enables PromoCell to serve the growing demand of researchers planning to work with PromoCell`s media under a regulated environment. This is achieved by a streamlined definition of raw material specifications and documentation required from their customers, thus reducing the regulatory burden, and ultimately saving cost and time.

Read the blog »»